Brief: Kronos Bio Q3 EPS USD -0.23
13/11/2024 21:05
Nov 13 (Reuters) - Kronos Bio Q3 basic EPS USD -0.23. * Q3 operating income USD -15.716 million * Q3 net income USD -14.108 million * Q3 operating expenses USD 18.086 million * Q3 cash & investments USD 124.9 million
Recent news on Kronos Bio
See all newsBrief: Kronos Bio Inc - Terminates Office Lease At 301 Binney Street - SEC Filing
Brief: Kronos Bio Inc - Enters Transition Agreement With Genentech
U.S. STOCKS ON THE MOVE - Ambarella, Dell, Nordstrom
U.S. STOCKS ON THE MOVE - Golden Ocean, Guess, Symbotic
U.S. STOCKS ON THE MOVE-HP, Urban Outfitters, 3D Systems